MedTrace Logo

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

NCT00662194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-03-10

No results posted yet for this study

Summary

Data from this study will provide the first information how the innate immune system may be altered in HIV-HCV and HIV-HBV co-infected individuals, and describe Toll-like receptor changes with HIV co-infection therapy.

Conditions

  • HIV-hepatitis Co-infection
  • HIV Infections

Sponsors & Collaborators

  • Monash Medical Centre

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • Joe Sasadeusz, MD, PhD · The Alfred

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2014-04-30
Completion
2014-10-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662194 on ClinicalTrials.gov